Glomerular filtration rate prior to high-dose melphalan 200 mg/m(2) as a surrogate marker of outcome in patients with myeloma

We correlated age and body surface area corrected glomerular filtration rate (GFR) at the time of high-dose melphalan (HDM) administration with treatment-related toxicity (TT), time to disease progression and survival. Between 8/85 and 6/98, 144 newly diagnosed myeloma patients with a median age of...

Descripción completa

Detalles Bibliográficos
Autores principales: Sirohi, B, Powles, R, Kulkarni, S, Rudin, C, Saso, R, Rigg, A, Horton, C, Singhal, S, Mehta, J, Treleaven, J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2001
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364060/
https://www.ncbi.nlm.nih.gov/pubmed/11487259
http://dx.doi.org/10.1054/bjoc.2000.1928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364060/
https://www.ncbi.nlm.nih.gov/pubmed/11487259
http://dx.doi.org/10.1054/bjoc.2000.1928

Ejemplares similares